12:00 AM
May 10, 1999
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Merck Research Laboratories preclinical data

Merck researchers published in Science the identification of a small molecule, L-783,281, that selectively activates the insulin receptor tyrosine kinase and acts...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >